Draft guideline on detection of toxicity to reproduction for medicinal products
Bass, R.; Ulbrich, B.; Hildebrandt, A.G.; Weissinger, J.; Doi, O.; Baeder, C.; Fumero, S.; Harada, Y.; Lehmann, H.; Manson, J.
Adverse Drug Reactions and Toxicological Reviews 10(3): 127-141
1991
ISSN/ISBN: 0964-198X PMID: 1747440 Document Number: 373743
Document emailed within 1 workday
Related Documents
Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76Romero, A.; Grau, M.T.; Villamayor, F.; Sacristán, A.; Ortiz, J.A. 1997: Toxicity of ebrotidine on reproduction. Toxicity on fertility and general reproductive performance, embryo-fetal toxicity and peri- and postnatal toxicity Arzneimittel-Forschung 47(4a): 504-510
2014: New draft guideline to prevent SSI Bulletin of the American College of Surgeons 99(8): 59-60
McGuckin, M.; Stineman, M.; Goin, J.; Williams, S. 1996: Draft guideline: diagnosis and treatment of venous leg ulcers Ostomy/Wound Management 42(4): 48; 50
Romero, A.; Grau, M.T.; Villamayor, F.; Sacristán, A.; Ortiz, J.A. 1992: Reproduction toxicity of sertaconazole. Segment Ii (teratology) and Segment IIi (peri-postnatal toxicity) Arzneimittel-Forschung 42(5a): 739-742
Semple, C.A. 2001: Bases and spaces: resources on the web for accessing the draft human genome - II - after publication of the draft Genome Biology 2(6): Reviews 2001
Morimoto, K.; Saitoh, M.; Hemmi, A.; Yamamoto, M.; Kaminuma, T. 1992: Preparation of the first draft of environmental health criteria for acetonitrile: production process of the draft Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 110: 73-77
Ernst, E. 2004: Risks of herbal medicinal products Pharmacoepidemiology and Drug Safety 13(11): 767-771
Kes, P.; Mesar, I.; Bašić-Jukić, N.; Rački, S. 2014: What doctors need to know about biosimilar medicinal products? Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 68(2): 201-205
Marimbert, J. 2005: Sanitary risk: medicinal products and medical devices La Revue du Praticien 55(18): 2026-2032
Rüsing, D.; Bauer, K.; Verspohl, E.J. 2004: Drug and medicinal products for the consumer. a critical evaluation Medizinische Monatsschrift für Pharmazeuten 27(3): 84-91
Kaye, S.; Ortiz, T.; Miranda Massari, J.R.; González, M.J. 2003: Adverse effects and interactions of medicinal herbal products Boletin de la Asociacion Medica de Puerto Rico 95(6): 32-36; 40-41
Bakhiet, A.O.; Adam, S.E. 1995: Therapeutic utility, constituents and toxicity of some medicinal plants: a review Veterinary and Human Toxicology 37(3): 255-258
Wiatrzyk, A.; Polak, M.; Czajka, U.; Krysztopa-Grzybowska, K.; Lutyńska, A. 2013: Phenotypic and genotypic characterization of probiotic bacterial strains used in medicinal products Medycyna Doswiadczalna i Mikrobiologia 65(1): 47-56
Kalny, P.; Wyderska, S.; Fijałek, Z.; Wroczyński, P. 2012: Determination of selected elements in different pharmaceutical forms of some Polish herbal medicinal products Acta Poloniae Pharmaceutica 69(2): 279-283
Elferink, A.J.; Toivonen, M.; van Bronswijk, H. 1999: Safety and efficacy of vigabatrin and carbamazepine. CPMP. The Committee for Proprietary Medicinal Products Lancet 354(9187): 1387-1388
Zmudzki, J. 2003: Risk analysis rules for the establishing of maximum residue limits of veterinary medicinal products Roczniki Panstwowego Zakladu Higieny 54 Suppl: 12-13
Vos, E.J.; Huitema, A.D.R. 2006: Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO) Nederlands Tijdschrift Voor Geneeskunde 150(38): 2104-2107
Várnagy, L.; Budai, P.; Molnár, E.; Takács, I.; Fejes, S. 2001: One-generation reproduction toxicity study of mancozeb and lead acetate Mededelingen 66(2b): 873-878
Ruys-Dudok van Heel, I.; Cohen, A.F.; Wit, J.M.; van der Heijden, A.J.; van den Anker, J.N.; van Meurs, A.H. 1998: Clinical drug research in children: current international guidelines. Committee for Proprietary Medicinal Products Nederlands Tijdschrift Voor Geneeskunde 142(1): 6-9